Antiparasitic Drugs Market Size, Share, Global Analysis Report, 2024-2032

Antiparasitic Drugs Market Share, Size, Trends, Industry Analysis Report, By Type (Antiprotozoals, Anthelmintics, Others); By Route of Administration; By Distribution Channel; By Region; Segment Forecast, 2024- 2032

Published Date:Jan-2024
Pages: 118
Format: PDF
Report ID: PM4409
Base Year: 2023
Historical Data: 2019 – 2022

Report Outlook

FAQ's

What is the expected industry size of Antiparasitic Drugs Market?

The global Antiparasitic Drugs market size is expected to reach USD 38.20 billion by 2032

Who are the top market players in the market?

Key players in the market are Bayer AG, Cipla Limited, F. Hoffmann-La Roche Ltd., GlaxoSmithKline

Which region contribute notably towards the global Antiparasitic Drugs Market?

North America contribute notably towards the global Antiparasitic Drugs Market

What will be the expected CAGR of Antiparasitic Drugs Market during the forecast period (2024-2032)?

Antiparasitic Drugs Market exhibiting the CAGR of 5.4% during the forecast period.

What are the key segments in the Antiparasitic Drugs Market?

The Antiparasitic Drugs Market report covering key segments are type, route of administration, distribution channel, and region.

1. Introduction
    1.1. Report Description
        1.1.1. Objectives of the Study
        1.1.2. Market Scope
        1.1.3. Assumptions
    1.2. Stakeholders
2. Executive Summary
    2.1. Market Highlights
3. Research Methodology
    3.1. Overview
        3.1.1. Data Mining
    3.2. Data Sources
        3.2.1. Primary Sources
        3.2.2. Secondary Sources
4. Global Antiparasitic Drugs Market Insights
    4.1. Antiparasitic Drugs Market – Distribution Channel Snapshot
    4.2. Antiparasitic Drugs Market Dynamics
        4.2.1. Drivers and Opportunities
            4.2.1.1. Global health initiatives are projected to spur the product demand
            4.2.1.2. Prevalence of parasitic infections is expected to drive antiparasitic drugs market growth
        4.2.2. Restraints and Challenges
            4.2.2.1. Regulatory challenges are likely to impede the market growth
    4.3. Porter’s Five Forces Analysis
        4.3.1. Bargaining Power of Suppliers (Moderate)
        4.3.2. Threats of New Entrants: (Low)
        4.3.3. Bargaining Power of Buyers (Moderate)
        4.3.4. Threat of Substitute (Moderate)
        4.3.5. Rivalry among existing firms (High)
    4.4. PESTEL Analysis
    4.5. Antiparasitic Drugs Market Distribution Channel Trends
    4.6. Value Chain Analysis
    4.7. COVID-19 Impact Analysis
5. Global Antiparasitic Drugs Market, by Type
    5.1. Key Findings
    5.2. Introduction
        5.2.1. Global Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
    5.3. Antiprotozoals
        5.3.1. Global Antiparasitic Drugs Market, by Antiprotozoals, by Region, 2019-2032 (USD Billion)
    5.4. Anthelmintics
        5.4.1. Global Antiparasitic Drugs Market, by Anthelmintics, by Region, 2019-2032 (USD Billion)
    5.5. Others
        5.5.1. Global Antiparasitic Drugs Market, by Others, by Region, 2019-2032 (USD Billion)
6. Global Antiparasitic Drugs Market, by Route of Administration
    6.1. Key Findings
    6.2. Introduction
        6.2.1. Global Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    6.3. Topical
        6.3.1. Global Antiparasitic Drugs Market, by Topical, by Region, 2019-2032 (USD Billion)
    6.4. Oral
        6.4.1. Global Antiparasitic Drugs Market, by Oral, by Region, 2019-2032 (USD Billion)
    6.5. Injectable
        6.5.1. Global Antiparasitic Drugs Market, by Injectable, by Region, 2019-2032 (USD Billion)
7. Global Antiparasitic Drugs Market, by Distribution Channel
    7.1. Key Findings
    7.2. Introduction
        7.2.1. Global Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
    7.3. Retail Pharmacy
        7.3.1. Global Antiparasitic Drugs Market, by Retail Pharmacy, By Region, 2019-2032 (USD Billion)
    7.4. Hospital Pharmacy
        7.4.1. Global Antiparasitic Drugs Market, by Hospital Pharmacy, By Region, 2019-2032 (USD Billion)
    7.5. Others
        7.5.1. Global Antiparasitic Drugs Market, by Others, By Region, 2019-2032 (USD Billion)
8. Global Antiparasitic Drugs Market, by Geography
    8.1. Key findings
    8.2. Introduction
        8.2.1. Antiparasitic Drugs Market Assessment, By Geography, 2019-2032 (USD Billion)
    8.3. Antiparasitic Drugs Market – North America
        8.3.1. North America: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
        8.3.2. North America: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
        8.3.3. North America: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
        8.3.4. Antiparasitic Drugs Market – U.S.
                    8.3.4.1. U.S.: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
                    8.3.4.2. U.S.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
                    8.3.4.3. U.S.: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
        8.3.5. Antiparasitic Drugs Market – Canada
            8.3.5.1. Canada: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
                8.3.5.2. Canada.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
            8.3.5.3. Canada: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    8.4. Antiparasitic Drugs Market – Europe
        8.4.1. Europe: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
            8.4.2. Europe.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
        8.4.3. Europe: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
        8.4.4. Antiparasitic Drugs Market – UK
            8.4.4.1. UK: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
                8.4.4.2. UK.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
            8.4.4.3. UK: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
        8.4.5. Antiparasitic Drugs Market – France
            8.4.5.1. France: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
                8.4.5.2. France.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
            8.4.5.3. France: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
        8.4.6. Antiparasitic Drugs Market – Germany
            8.4.6.1. Germany: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
                8.4.6.2. Germany.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
            8.4.6.3. Germany: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
        8.4.7. Antiparasitic Drugs Market – Italy
            8.4.7.1. Italy: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
                8.4.7.2. Italy.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
            8.4.7.3. Italy: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
        8.4.8. Antiparasitic Drugs Market – Spain
            8.4.8.1. Spain: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
                8.4.8.2. Spain.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
            8.4.8.3. Spain: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
        8.4.9. Antiparasitic Drugs Market – Netherlands
            8.4.9.1. Netherlands: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
                8.4.9.2. Netherlands.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
            8.4.9.3. Netherlands: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
        8.4.10. Antiparasitic Drugs Market – Russia
            8.4.10.1. Russia: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
                8.4.10.2. Russia.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
            8.4.10.3. Russia: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    8.5. Antiparasitic Drugs Market – Asia Pacific
        8.5.1. Asia Pacific: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
        8.5.2. Asia Pacific.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
        8.5.3. Asia Pacific: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
        8.5.4. Antiparasitic Drugs Market – China
            8.5.4.1. China: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
                8.5.4.2. China.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
            8.5.4.3. China: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
        8.5.5. Antiparasitic Drugs Market – India
            8.5.5.1. India: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
                8.5.5.2. India.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
            8.5.5.3. India: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
        8.5.6. Antiparasitic Drugs Market – Malaysia
            8.5.6.1. Malaysia: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
                8.5.6.2. Malaysia.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
            8.5.6.3. Malaysia: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
        8.5.7. Antiparasitic Drugs Market – Japan
            8.5.7.1. Japan: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
                8.5.7.2. Japan.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
            8.5.7.3. Japan: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
        8.5.8. Antiparasitic Drugs Market – Indonesia
            8.5.8.1. Indonesia: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
                8.5.8.2. Indonesia.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
            8.5.8.3. Indonesia: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
        8.5.9. Antiparasitic Drugs Market – South Korea
            8.5.9.1. South Korea: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
            8.5.9.2. South Korea.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
            8.5.9.3. South Korea: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    8.6. Antiparasitic Drugs Market – Middle East & Africa
        8.6.1. Middle East & Africa: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
        8.6.2. Middle East & Africa.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
        8.6.3. Middle East & Africa: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
        8.6.4. Antiparasitic Drugs Market – Saudi Arabia
            8.6.4.1. Saudi Arabia: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
            8.6.4.2. Saudi Arabia.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
            8.6.4.3. Saudi Arabia: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
        8.6.5. Antiparasitic Drugs Market – UAE
            8.6.5.1. UAE: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
                8.6.5.2. UAE.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
            8.6.5.3. UAE: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
        8.6.6. Antiparasitic Drugs Market – Israel
            8.6.6.1. Israel: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
                8.6.6.2. Israel.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
            8.6.6.3. Israel: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
        8.6.7. Antiparasitic Drugs Market – South Africa
            8.6.7.1. South Africa: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
            8.6.7.2. South Africa.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
            8.6.7.3. South Africa: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    8.7. Antiparasitic Drugs Market – Latin America
        8.7.1. Latin America: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
        8.7.2. Latin America.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
        8.7.3. Latin America: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
        8.7.4. Antiparasitic Drugs Market – Mexico
            8.7.4.1. Mexico: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
                8.7.4.2. Mexico.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
            8.7.4.3. Mexico: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
        8.7.5. Antiparasitic Drugs Market – Brazil
            8.7.5.1. Brazil: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
                8.7.5.2. Brazil.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
            8.7.5.3. Brazil: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
        8.7.6. Antiparasitic Drugs Market – Argentina
            8.7.6.1. Argentina: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
                8.7.6.2. Argentina.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
            8.7.6.3. Argentina: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
9. Competitive Landscape
    9.1. Expansion and Acquisition Analysis
        9.1.1. Expansion
        9.1.2. Acquisitions
    9.2. Partnerships/Collaborations/Agreements/Exhibitions
10. Company Profiles
    10.1. AstraZeneca
        10.1.1. Company Overview
        10.1.2. Financial Performance
        10.1.3. Product Benchmarking
        10.1.4. Recent Development
   10.2. Bayer AG
        10.2.1. Company Overview
        10.2.2. Financial Performance
        10.2.3. Product Benchmarking
        10.2.4. Recent Development
    10.3. Cipla Limited
        10.3.1. Company Overview
        10.3.2. Financial Performance
        10.3.3. Product Benchmarking
        10.3.4. Recent Development
    10.4. Dr. Reddy's Laboratories
        10.4.1. Company Overview
        10.4.2. Financial Performance
        10.4.3. Product Benchmarking
        10.4.4. Recent Development
    10.5. F. Hoffmann-La Roche Ltd
        10.5.1. Company Overview
        10.5.2. Financial Performance
        10.5.3. Product Benchmarking
        10.5.4. Recent Development
    10.6. GlaxoSmithKline
        10.6.1. Company Overview
        10.6.2. Financial Performance
        10.6.3. Product Benchmarking
        10.6.4. Recent Development
    10.7. Ipca Laboratories Ltd
        10.7.1. Company Overview
        10.7.2. Financial Performance
        10.7.3. Product Benchmarking
        10.7.4. Recent Development
    10.8. Lupin Pharmaceuticals
        10.8.1. Company Overview
        10.8.2. Financial Performance
        10.8.3. Product Benchmarking
        10.8.4. Recent Development
    10.9. Merck & Co.
        10.9.1. Company Overview
        10.9.2. Financial Performance
        10.9.3. Product Benchmarking
        10.9.4. Recent Development
    10.10. Novartis
        10.10.1. Company Overview
        10.10.2. Financial Performance
        10.10.3. Product Benchmarking
        10.10.4. Recent Development
    10.11. Pfizer
        10.11.1. Company Overview
        10.11.2. Financial Performance
        10.11.3. Product Benchmarking
        10.11.4. Recent Development
    10.12. Sanofi
        10.12.1. Company Overview
        10.12.2. Financial Performance
        10.12.3. Product Benchmarking
        10.12.4. Recent Development
    10.13. Sun Pharmaceutical Industries Ltd.
        10.13.1. Company Overview
        10.13.2. Financial Performance
        10.13.3. Product Benchmarking
        10.13.4. Recent Development
    10.14. Viatris
        10.14.1. Company Overview
        10.14.2. Financial Performance
        10.14.3. Product Benchmarking
        10.14.4. Recent Development
    10.15. Zydus Group
        10.15.1. Company Overview
        10.15.2. Financial Performance
        10.15.3. Product Benchmarking
        10.15.4. Recent Development

List of Tables

Table 1 Global Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
Table 2 Global Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
Table 3 Global Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
Table 4 Antiparasitic Drugs Market Assessment, By Geography, 2019-2032 (USD Billion)
Table 5 North America: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
Table 6 North America: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
Table 7 North America: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
Table 8 U.S.: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
Table 9 U.S.: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
Table 10 U.S.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
Table 11 Canada: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
Table 12 Canada: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
Table 13 Canada: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
Table 14 Europe: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
Table 15 Europe: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
Table 16 Europe: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
Table 17 UK: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
Table 18 UK: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
Table 19 UK: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
Table 20 France: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
Table 21 France: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
Table 22 France: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
Table 23 Germany: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
Table 24 Germany: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
Table 25 Germany: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
Table 26 Italy: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
Table 27 Italy: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
Table 28 Italy: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
Table 29 Spain: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
Table 30 Spain: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
Table 31 Spain: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
Table 32 Netherlands: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
Table 33 Netherlands: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
Table 34 Netherlands: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
Table 35 Russia: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
Table 36 Russia: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
Table 37 Russia: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
Table 38 Asia Pacific: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
Table 39 Asia Pacific: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
Table 40 Asia Pacific: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
Table 41 China: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
Table 42 China: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
Table 43 China: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
Table 44 India: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
Table 45 India: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
Table 46 India: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
Table 47 Malaysia: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
Table 48 Malaysia: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
Table 49 Malaysia: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
Table 50 Japan: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
Table 51 Japan: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
Table 52 Japan: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
Table 53 Indonesia: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
Table 54 Indonesia: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
Table 55 Indonesia: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
Table 56 South Korea: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
Table 57 South Korea: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
Table 58 South Korea: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
Table 59 Middle East & Africa: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
Table 60 Middle East & Africa: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
Table 61 Middle East & Africa: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
Table 62 Saudi Arabia: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
Table 63 Saudi Arabia: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
Table 64 Saudi Arabia: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
Table 65 UAE: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
Table 66 UAE: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
Table 67 UAE: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
Table 68 Israel: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
Table 69 Israel: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
Table 70 Israel: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
Table 71 South Africa: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
Table 72 South Africa: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
Table 73 South Africa: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
Table 74 Latin America: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
Table 75 Latin America: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
Table 76 Latin America: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
Table 77 Mexico: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
Table 78 Mexico: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
Table 79 Mexico: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
Table 80 Brazil: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
Table 81 Brazil: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
Table 82 Brazil: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
Table 83 Argentina: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
Table 84 Argentina: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
Table 85 Argentina: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)

List of Figures

Figure 1. Global Antiparasitic Drugs Market, 2019-2032 (USD Billion)
Figure 2. Integrated Ecosystem
Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
Figure 4. Market by Geography
Figure 5. Porter’s Five Forces
Figure 6. Market by Route of Administration
Figure 7. Global Antiparasitic Drugs Market, by Route of Administration, 2022 & 2032 (USD Billion)
Figure 8. Market by Type
Figure 9. Global Antiparasitic Drugs Market, by Type, 2022 & 2032 (USD Billion)
Figure 10. Market by Distribution Channel
Figure 11. Global Antiparasitic Drugs Market, by Distribution Channel, 2022 & 2032 (USD Billion)
Figure 12. Antiparasitic Drugs Market Assessment, By Geography, 2019-2032 (USD Billion)
Figure 13. Strategic Analysis – Antiparasitic Drugs Market

Report Scope

Antiparasitic Drugs Market, Type Outlook (Revenue - USD Billion, 2019-2032)

Antiprotozoals
Anthelmintics
Others

Antiparasitic Drugs Market, Route of Administration Outlook (Revenue - USD Billion, 2019-2032)

Topical
Oral
Injectable

Antiparasitic Drugs Market, Distribution Channel Outlook (Revenue - USD Billion, 2019-2032)

Retail Pharmacy
Hospital Pharmacy
Others

Antiparasitic Drugs Market, Regional Outlook (Revenue - USD Billion, 2019-2032)

North America
- Type Outlook
  - Antiprotozoals
  - Anthelmintics
  - Others
- Route of Administration Outlook
  - Topical
  - Oral
  - Injectable
- Distribution Channel Outlook
  - Retail Pharmacy
  - Hospital Pharmacy
  - Others
Europe
- Type Outlook
  - Antiprotozoals
  - Anthelmintics
  - Others
- Route of Administration Outlook
  - Topical
  - Oral
  - Injectable
- Distribution Channel Outlook
  - Retail Pharmacy
  - Hospital Pharmacy
  - Others
Asia Pacific
- Type Outlook
  - Antiprotozoals
  - Anthelmintics
  - Others
- Route of Administration Outlook
  - Topical
  - Oral
  - Injectable
- Distribution Channel Outlook
  - Retail Pharmacy
  - Hospital Pharmacy
  - Others
Latin America
- Type Outlook
  - Antiprotozoals
  - Anthelmintics
  - Others
- Route of Administration Outlook
  - Topical
  - Oral
  - Injectable
- Distribution Channel Outlook
  - Retail Pharmacy
  - Hospital Pharmacy
  - Others
Middle East & Africa
- Type Outlook
  - Antiprotozoals
  - Anthelmintics
  - Others
- Route of Administration Outlook
  - Topical
  - Oral
  - Injectable
- Distribution Channel Outlook
  - Retail Pharmacy
  - Hospital Pharmacy
  - Others

Quantitative Analysis

Market size, estimates, and forecasts from 2019-2032
Market size and revenue estimates for Type up to 2032
Market revenue estimates for Route of Administration up to 2032
Market revenue estimates for distribution channel up to 2032
Regional market size and forecast up to 2032
Company financials

Request Free Sample

Please fill out the form to receive sample pages of the report.

We take great pride in "Delivering game-changing business opportunities reports with report customizations", so please don't hesitate to share with us your unique interests and business difficulties in much more detail.

By using this form you agree with the storage and handling of your data by this website.

This website is secure and your personal details are safe. Privacy Policy

Antiparasitic Drugs Market Size, Share, Global Analysis Report, 2024-2032

What's Included in Full Report?

Request Sample Report